Deferasirox

FDA Approved: * January 26, 2016
Pharm Company: * ACTAVIS ELIZABETH
Category: Iron Chelator

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Deferasirox Overview

Deferasirox (marketed as Exjade,[2] Desirox, Defrijet, Desifer, Rasiroxpine and Jadenu) is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.[3][4] It is the first oral medication approved in the USA for this purpose.[5] It was approved by the United States Food and Drug Administration...

Read more Deferasirox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Deferasirox

Recent Deferasirox Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Deferasirox
  • Tablet: 180mb, 180mg, 360mg, 90mg
  • Tablet, Film Coated: 90 Mg, 180 Mg, 360 Mg.
  • Tablet, For Suspension: 125mg, 250mg, 500mg
  • Tablet, Orally Disintegrating: 500mg
  • Unknown: Unknown
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Deferasirox: (57 results)

Showing the first 20, Sorted by National Drug Code
  • 0078-0654 Jadenu 90 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0655 Jadenu 180 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0656 Jadenu 360 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0093-3515 Deferasirox 360 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-3517 Deferasirox 90 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0591-3853 Deferasirox 180 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 16714-993 Deferasirox 90 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-995 Deferasirox 360 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 43598-851 Deferasirox 360 mg Oral Tablet by Dr. Reddy's Laboratories Inc
  • 43598-853 Deferasirox 90 mg Oral Tablet by Dr. Reddy's Laboratories Inc
  • 43598-854 Deferasirox 500 mg Oral Tablet, for Suspension by Dr. Reddy's Laboratories Inc
  • 43598-855 Deferasirox 125 mg Oral Tablet, for Suspension by Dr. Reddy's Laboratories Inc
  • 43598-856 Deferasirox 250 mg Oral Tablet, for Suspension by Dr. Reddy's Laboratories Inc
  • 45963-454 Deferasirox 125 mg Oral Tablet, for Suspension by Actavis Pharma, Inc.
  • 45963-455 Deferasirox 250 mg Oral Tablet, for Suspension by Actavis Pharma, Inc.
  • 45963-456 Deferasirox 500 mg Oral Tablet, for Suspension by Actavis Pharma, Inc.
  • 46708-324 Deferasirox 125 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Limited
  • 46708-325 Deferasirox 250 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Limited
  • 46708-326 Deferasirox 500 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Limited
  • 46708-410 Deferasirox 90 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 37 more results ...

Other drugs which contain Deferasirox or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 26 May 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA